Nabity-Jensen Investment Management’s Pfizer PFE Stock Holding History

Nabity-Jensen Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$229K	Buy	8,141 +26	+0.3%	+$692	0.16%	70
2025 Q4	$202K	Buy	8,115 +91	+1%	+$2.29K	0.14%	70
2025 Q3	$204K	Sell	8,024 -2,564	-24%	-$63.3K	0.14%	69
2025 Q2	$257K	Sell	10,588 -1,497	-12%	-$34.9K	0.19%	62
2025 Q1	$306K	Buy	12,085 +100	+0.8%	+$2.62K	0.24%	58
2024 Q4	$318K	Hold	11,985	–	–	0.24%	56
2024 Q3	$347K	Hold	11,985	–	–	0.27%	54
2024 Q2	$335K	Sell	11,985 -400	-3%	-$11K	0.27%	53
2024 Q1	$344K	Sell	12,385 -821	-6%	-$22.8K	0.28%	51
2023 Q4	$380K	Buy	+13,206	New	+$399K	0.34%	47

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Nabity-Jensen Investment Management's PFE Position: Q1 2026 in Review

Nabity-Jensen Investment Management increased its Pfizer (PFE) stake by 0.32% in Q1 2026, buying an estimated $692 and bringing the position to 8,141 shares worth $229K. The position accounts for 0.16% of the portfolio, ranked #70.

Nabity-Jensen Investment Management first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $380K in Q4 2023. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Nabity-Jensen Investment Management held 8,141 shares of Pfizer worth $229K as of Q1 2026.
Nabity-Jensen Investment Management bought 26 Pfizer shares in Q1 2026, an estimated $692.
Pfizer made up 0.16% of Nabity-Jensen Investment Management's portfolio in Q1 2026, its #70 holding.
Nabity-Jensen Investment Management first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
Nabity-Jensen Investment Management's Pfizer position peaked at $380K in Q4 2023.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Nabity-Jensen Investment Management's 13F filing for Q1 2026, filed 21 Apr 2026.